Similar Glucose Control and Hypoglycemia but Reduced Glucose Variability with Glucose Dependent and Independent Therapies in Older Patients with Type 2 Diabetes Mellitus (T2DM)

被引：0

作者：

Pratley, Richard E.

Rosenstock, Julio

Heller, Simon R.

Sinclair, Alan

Heine, Robert J.

Kiljanski, Jacek

Brusko, Cynthia S.

Duan, Ran

Festa, Andreas

机构：

来源：

DIABETES | 2016年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

891-P

引用

页码：A229 / A229

页数：1

共 50 条

[21] In Patients with Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring System (CGMS) Usage Does Not Alter Multiple Measures of Glycemic Variability (GV)
Lee, Yee Liong
Mehfooz, Ayesha
Wang, Qi
Chow, Lisa S.
DIABETES, 2022, 71
[22] Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM)
Hinke, Simon A.
Pederson, Raymond A.
McIntosh, Christopher H. S.
DIPEPTIDYL AMINOPEPTIDASES: BASIC SCIENCE AND CLINICAL APPLICATIONS, 2006, 575 : 119 - 133
[23] RESEARCH ON THE INCIDENCE AND COST OF HYPOGLYCEMIA EPISODE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Zheng, Y.
Wu, J.
Oesterle, A.
VALUE IN HEALTH, 2012, 15 (07) : A504 - A505
[24] Physician beliefs in efficacy of insulin glargine (GLAR) are associated with glucose control in type 2 diabetes (T2DM)
Herman, W.
Zhang, Q.
Kennedy, L.
DIABETOLOGIA, 2006, 49 : 527 - 528
[25] OPTIMAL GLUCOSE CONTROL in Type 2 Diabetes Mellitus
Van Zyl, D. G.
SA PHARMACEUTICAL JOURNAL, 2007, 74 (06) : 38 - 44
[26] Effect of Liraglutide on Time to Post-challenge Peak Glucose in Patients with Type 2 Diabetes (T2DM)
Tran, Susan
Kramer, Caroline K.
Zinman, Bernard
Choi, Haysook
Retnakaran, Ravi
DIABETES, 2017, 66 : A288 - A288
[27] Sustained effects of intensive glucose control in established T2DM
Joana Osório
Nature Reviews Endocrinology, 2014, 10 (9) : 512 - 512
[28] The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes
Monnier, Louis
Wojtusciszyn, Anne
Colette, Claude
Owens, David
DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (08) : 813 - 818
[29] LY2599506, a Novel Glucokinase Activator (GKA), Improves Fasting and Postprandial Glucose in Patients with Type 2 Diabetes Mellitus (T2DM)
Bue-Valleskey, Juliana M.
Schneck, Karen B.
Sinha, Vikram P.
Wondmagegnehu, Eshetu T.
Kapitza, Christoph
Miller, Jeffrey W.
DIABETES, 2011, 60 : A272 - A272
[30] PERSONALIZED FORECASTING OF SEVERE HYPOGLYCEMIA USING REAL-TIME CONTINUOUS GLUCOSE MONITORING (CGM) DATA IN PATIENTS WITH TYPE 2 DIABETES (T2DM)
Ma, S.
Kirsh, T.
Chow, L.
DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A113 - A114

← 1 2 3 4 5 →